News Roche Holding AG

Stocks

ROP

CH1499059983

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 16:30:33 10/07/2026 BST			5-day change	1st Jan Change
336.60 ^CHF	+0.33%		-1.17%	+2.56%

07-09	Roche's Tuberculosis Test Receives CE Mark	MT
07-08	ABB Robotics Partners with Roche Diagnostics	MT

All News

Mentions Relevance

07-09	Roche's Tuberculosis Test Receives CE Mark	MT
07-08	ABB Robotics Partners with Roche Diagnostics	MT
07-07	Roche Presents New Data in Alzheimer?S Disease Portfolio At Aaic 2026	CI
07-07	Genentech and Roche Present New Data in Alzheimer’s Disease From Across Its Integrated Pharmaceutical and Diagnostics Portfolio at AAIC	BU
07-06	HSBC Downgrades Roche to Hold Rating	MT
07-02	Roche Reports Positive Results from Phase Iii Krascendo 1 Study Evaluating Divarasib Against Approved Kras G12c Inhibitors in Previously Treated Kras G12c Non-Small Cell Lung Cancer	CI
07-02	Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial	DJ
07-02	Roche's Non-small Cell Lung Cancer Drug Meets Primary, Key Secondary Endpoint in Late-stage Trial	MT
07-02	Genentech’s Divarasib Shows Superiority in Head-to-Head Phase III Trial Against Approved KRAS G12C Inhibitors in Non-Small Cell Lung Cancer	BU
06-30	FDA grants Priority Review to Roche's Enspryng, the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)	AQ
06-30	ROCHE HOLDINGS AG : Goldman Sachs sticks Neutral	ZD
06-30	Roche Announces FDA Acceptance and Priority Review of Supplemental Biologics License Application for Enspryng for Thyroid Eye Disease	CI
06-30	Roche Receives US Priority Review Status for Thyroid Eye Disease Treatment	MT
06-30	FDA Grants Priority Review To Genentech’s Application for Enspryng, the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)	BU
06-29	Excalipoint Therapeutics And Roches Announce Clinical Trial Collaboration To Evaluate EXP011 In DLL3-Expressing Solid Tumors	CI
06-29	Roche takes aim at Illumina's dominance with new gene sequencing machine	RE
06-29	Roche launches Axelios gene sequencer in a bid to loosen Illumina's grip	RE
06-29	Roche Announces Launch Of AXELIOS 1 Sequencing Platform	CI
06-29	Switzerland's Roche Introduces New Sequencing Platform	MT
06-24	Roche Holding AG Announces FDA Grants Priority Review Status to its Atezolizumab for Treatment of Certain Type of Stage III Colorectal Cancer	CI
06-18	FDA Approves First Generic Single-Dose Flu Treatment	DJ
06-18	Roche Receives FDA Acceptance for Supplemental Biologics License Application For Lunsumio And Polivy Combination For Relapsed Or Refractory Large B-Cell Lymphoma	CI
06-18	Roche Wins US FDA Nod for Lymphoma Drug Combo	MT
06-18	FDA Accepts Supplemental Biologics License Application for Genentech’s Lunsumio and Polivy Combination for People With Relapsed or Refractory Large B-Cell Lymphoma	BU
06-18	Swiss stocks - Factors to watch on June 18	RE